Literature DB >> 7998827

Inhalation toxicokinetics of butoxyethanol and its metabolite butoxyacetic acid in the male Sprague-Dawley rat.

G Johanson1.   

Abstract

A total of 16 male Sprague-Dawley rats were continuously exposed to 20 ppm or 100 ppm butoxyethanol (BE) vapor for 1, 2, 3, 4, 6, 8, 10, or 12 days. Urine was collected in 24-h intervals and stored at -70 degrees C. At the end of the exposure the animals were euthanized by decapitation and tissue samples of blood, muscle, liver and were rapidly collected and frozen to -70 degrees C. The samples were later derivatized and analyzed for BE and its major metabolite butoxyacetic acid (BAA) by electron capture gas chromatography. BE and BAA were rapidly distributed to the tissues examined. The concentration of BE in blood was slightly higher, and that of BAA markedly higher than in other tissues, indicating weak (BE) and pronounced (BAA) blood protein binding, respectively. BE was efficiently metabolized and the blood clearance averaged 2.6 l/h per kg, corresponding to a hepatic extraction ratio of about 0.75. The renal clearance of BAA (average 0.53 l/h per kg) corresponded to approximately 15% of the renal blood flow. The kinetics of BE and BAA were linear up to 100 ppm. There were no clear indications of changes in the toxicokinetics, such as metabolic induction or inhibition of metabolism or excretion, during the course of the exposure. The recovery of BAA in urine was 64% of the calculated inhaled amount of BE, on an equimolar basis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998827     DOI: 10.1007/s002040050119

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  26 in total

1.  Metabolic and cellular basis of 2-butoxyethanol-induced hemolytic anemia in rats and assessment of human risk in vitro.

Authors:  B I Ghanayem
Journal:  Biochem Pharmacol       Date:  1989-05-15       Impact factor: 5.858

2.  Analysis of ethylene glycol ether metabolites in urine by extractive alkylation and electron-capture gas chromatography.

Authors:  G Johanson
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  Effect of exposure concentration on the disposition of inhaled butoxyethanol by F344 rats.

Authors:  P J Sabourin; M A Medinsky; L S Birnbaum; W C Griffith; R F Henderson
Journal:  Toxicol Appl Pharmacol       Date:  1992-06       Impact factor: 4.219

4.  Acute toxicity and recovery in the hemopoietic system of rats after treatment with ethylene glycol monomethyl and monobutyl ethers.

Authors:  D Grant; S Sulsh; H B Jones; S D Gangolli; W H Butler
Journal:  Toxicol Appl Pharmacol       Date:  1985-02       Impact factor: 4.219

5.  Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases.

Authors:  B I Ghanayem; L T Burka; H B Matthews
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

6.  Percutaneous uptake rate of 2-butoxyethanol in the guinea pig.

Authors:  G Johanson; P Fernström
Journal:  Scand J Work Environ Health       Date:  1986-10       Impact factor: 5.024

7.  Gas chromatographic determination of butoxyacetic acid in human blood after exposure to 2-butoxyethanol.

Authors:  G Johanson; S Johnsson
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

8.  Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms.

Authors:  B I Ghanayem; I M Sanchez; H B Matthews
Journal:  Toxicol Appl Pharmacol       Date:  1992-02       Impact factor: 4.219

9.  Toxicokinetics of inhaled 2-butoxyethanol (ethylene glycol monobutyl ether) in man.

Authors:  G Johanson; H Kronborg; P H Näslund; M Byfält Nordqvist
Journal:  Scand J Work Environ Health       Date:  1986-12       Impact factor: 5.024

10.  Elimination kinetics of 2-butoxyethanol in the perfused rat liver--dose dependence and effect of ethanol.

Authors:  G Johanson; M Wallén; M Byfält Nordqvist
Journal:  Toxicol Appl Pharmacol       Date:  1986-04       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.